MarketLens

What Did Arcus Biosciences Highlight at the Goldman Sachs Healthcare Conference

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Did Donaldson Highlight at the William Blair Conference

3 months ago

Why Did Goldman Sachs Downgrade BioArctic

4 months ago

What Do Recent Congressional Trades in Goldman Sachs Signal

4 months ago

Why Did Goldman Sachs Double Downgrade Best Buy

5 months ago

Arcus Biosciences, Inc. (RCUS) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Arcus Biosciences presented at Citigroup's Biopharma Back to School Summit 2026, discussing pipeline updates. No financial figures or guidance changes were disclosed in the transcript.

RCUS

Stock News•3 weeks ago

Precision BioSciences: Promising HBV Editing Evidence

Precision BioSciences' PBGENE-HBV liver biopsy data directly shows ARCUS editing the viral reservoir in patients, though durable off-treatment control remains unproven. Next ELIMINATE-B updates are de...

DTIL

Stock News•4 weeks ago

Tango Therapeutics: Promising Early Data, But A Long Road Ahead

Tango Therapeutics' vopimetostat plus daraxonrasib showed an unusually strong early pancreatic-cancer signal in a small, previously treated cohort. A planned front-line Phase 3 trial could expand the ...

TNGX

Breaking News

Clinical Trials (Phase I, II, III)

Creator Economy

Crude Oil (WTI/Brent)

Top Headlines

View More →

Stock News•2 hours ago

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Stock News•2 hours ago

Viral AI Dommer Tweet: Engineered Panic?

Stock News•3 hours ago

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Stock News•4 hours ago

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Stock News•6 hours ago

What Did Arcus Biosciences Highlight at the Goldman Sachs Healthcare Conference

Exclusive Content for Pro Members

Related Articles

What Did Donaldson Highlight at the William Blair Conference

Why Did Goldman Sachs Downgrade BioArctic

What Do Recent Congressional Trades in Goldman Sachs Signal

Why Did Goldman Sachs Double Downgrade Best Buy

Category

You may also like

Arcus Biosciences, Inc. (RCUS) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Precision BioSciences: Promising HBV Editing Evidence

Tango Therapeutics: Promising Early Data, But A Long Road Ahead

Breaking News

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Top Headlines

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Viral AI Dommer Tweet: Engineered Panic?

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Warren Buffett Made Apple Berkshire Hathaway's Single Largest Stock Position: $10,000 Invested 10 Years Ago Would Be Worth Roughly $122,400 Today